Clinical characteristics of 116 patients with solitary plasmacytoma of bone
Characteristic . | N . | %* . |
---|---|---|
Sex | ||
Male | 82 | 70 |
Female | 34 | 30 |
Age, y | ||
0 to 49 | 33 | 28 |
50 to 59 | 23 | 20 |
60 to 69 | 29 | 25 |
70+ | 31 | 27 |
Serum monoclonal protein type | ||
No M protein | 42 | 36 |
IgG | 57 | 49 |
IgA | 10 | 9 |
Light chain only | 4 | 3 |
IgM | 1 | 1 |
Biclonal | 2 | 2 |
Size of serum monoclonal protein, g/dL | ||
0.5 or more | 63 | 54 |
0.51 to 1.0 | 11 | 10 |
1.1 to 1.99 | 29 | 25 |
2.0 or more | 13 | 11 |
Urine monoclonal protein type | ||
Not done | 11 | 10 |
Kappa | 32 | 27 |
Lambda | 10 | 9 |
No monoclonal protein | 63 | 54 |
Site of plasmacytoma | ||
Skull | 5 | 4 |
Spine | 49 | 45 |
Pelvis | 17 | 16 |
Long bones | 14 | 13 |
Ribs | 14 | 13 |
Other | 0 | 9 |
Dose of radiation | ||
No radiation | 4 | 3 |
Less than 3000 | 1 | 1 |
3000 to 3999 | 13 | 12 |
4000 to 4999 | 42 | 39 |
5000 to 5999 | 32 | 30 |
6000 or more | 4 | 3 |
Unknown | 13 | 12 |
Characteristic . | N . | %* . |
---|---|---|
Sex | ||
Male | 82 | 70 |
Female | 34 | 30 |
Age, y | ||
0 to 49 | 33 | 28 |
50 to 59 | 23 | 20 |
60 to 69 | 29 | 25 |
70+ | 31 | 27 |
Serum monoclonal protein type | ||
No M protein | 42 | 36 |
IgG | 57 | 49 |
IgA | 10 | 9 |
Light chain only | 4 | 3 |
IgM | 1 | 1 |
Biclonal | 2 | 2 |
Size of serum monoclonal protein, g/dL | ||
0.5 or more | 63 | 54 |
0.51 to 1.0 | 11 | 10 |
1.1 to 1.99 | 29 | 25 |
2.0 or more | 13 | 11 |
Urine monoclonal protein type | ||
Not done | 11 | 10 |
Kappa | 32 | 27 |
Lambda | 10 | 9 |
No monoclonal protein | 63 | 54 |
Site of plasmacytoma | ||
Skull | 5 | 4 |
Spine | 49 | 45 |
Pelvis | 17 | 16 |
Long bones | 14 | 13 |
Ribs | 14 | 13 |
Other | 0 | 9 |
Dose of radiation | ||
No radiation | 4 | 3 |
Less than 3000 | 1 | 1 |
3000 to 3999 | 13 | 12 |
4000 to 4999 | 42 | 39 |
5000 to 5999 | 32 | 30 |
6000 or more | 4 | 3 |
Unknown | 13 | 12 |
Percentages may not total 100 because of rounding.